P. Voutsinas

Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial

H. Milionis, E. Michelakis, E. Giamarellos‐Bourboulis, 2021, Infectious Diseases and Therapy.

Oral clarithromycin in COVID-19 of moderate severity: the ACHIEVE open-label trial using concurrent matched comparators

K. Syrigos, H. Milionis, E. Michelakis, 2020, medRxiv.